Dexamethasone reduced mortality among patients hospitalized with COVID-19, especially those who were also receiving respiratory support.

The first to launch was the ACTT-1 trial, though it didn't have that name when it began at the University of Nebraska Medical ...

Researchers in a new study has found that the administration of DXM after unilateral total knee arthroplasty (TKA) can ...

Dexamethasone can cause side effects that range from mild to serious. More common side effects include fluid buildup and acne. If dexamethasone side effects become difficult to tolerate ...

During a Case-Based Roundtable® event, Robert Z. Orlowski, MD, PhD, discussed the case of a patient who had progression of ...

The FDA has sent its first untitled letter of 2025, hitting Edenbridge Pharmaceuticals with a notice after assessin | The FDA ...

Cordyceps Sunshine Biotech Holdings Co., Ltd. 【C.S Group】, in collaboration with the Chinese Herbal Fungi Industry Research and Development Association (CHFIRDA), hosted the "Pharmacological ...

The results of the Phase III APEX study, which compared the use of bortezomib with dexamethasone in patients with relapsed or refractory MM, revealed that addition of bortezomib resulted in a ...

Researchers find four coordinated gene expression programs in immune cells from glioma tumors, including two that could lead ...

New findings from researchers at the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute could help make immunotherapies for brain cancer more effective. The team analyzed almost ...

Paris: Sanofi has announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan has approved Sarclisa, in combination with bortezomib, lenalidomide, and dexamethasone (VRd), for ...

Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma Approval offers access to new treatment options for newly diagnosed ...